Mindfulness Based Cognitive TherapyMEROCNCT07069361
Mindful Emotion Regulation in Organizational Contexts
A study testing Mindfulness-Based Cognitive Therapy - Life Course Adaptation (MBCT-L) in people with Mindfulness Based Cognitive Therapy and Wait-List Control, run by University of Bucharest at 1 site in Romania.
Trial summary
This randomized controlled trial investigates the effects of an 8-week mindfulness-based interventions, Mindfulness for Life (MBCT-L) on daily emotion regulation, psychological functioning, and work-related outcomes. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Mindfulness Based Cognitive Therapy, Wait-List Control, Emotion Regulation
- What is being tested?
- Mindfulness-Based Cognitive Therapy - Life Course Adaptation (MBCT-L)
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 340 participants
- Where
- 1 siteRomania
- Study dates
- 30 Jul 2025to 12 Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Age between 18 and 65 years
- Full-time Workers
Who cannot join
- Experiencing Hallucinations
- Experiencing psychotic symptoms
- Recieving psychotropic medications
- Experiencing legal or health issues that would prevent them to attend the sessions.
- Have had participated in a Mindfulness-Based course in the last 2 years.
- Presenting symptoms of intellectual disability, communication disorders or neurocognitive disorders
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Role of Mindful Emotion Regulation in Organizational Contexts: A Workplace Experiment
This randomized controlled trial investigates the effects of an 8-week mindfulness-based interventions, Mindfulness for Life (MBCT-L) on daily emotion regulation, psychological functioning, and work-related outcomes. The primary objective of this study is to investigate the underlying mechanism of change between mindfulness and job performance and satisfaction.
Read the detailed description
This study investigates the mechanisms by which mindfulness training influences positive affect, job performance, and satisfaction in organizational settings. Employing a two-period crossover design, participants receive an 8-week Mindfulness for Life (MBCT-L) intervention. Guided by Mindfulness-to-Meaning theory, the investigator propose that increases in mindfulness enhance positive affect through improved decentering and positive reframing. In line with the Broaden-and-Build theory, it is hypothesized that heightened positive affect leads to better in-role job performance and higher job satisfaction by increasing psychological capital. The primary objective is to elucidate these mediational pathways, thereby advancing our understanding of how mindfulness interventions can foster improve emotion regulation and organizational functioning.
- Conditions
- Mindfulness Based Cognitive Therapy, Wait-List Control, Emotion Regulation, Organizational Context
- Being tested
- Mindfulness-Based Cognitive Therapy - Life Course Adaptation (MBCT-L)
- Keywords
- Mindfulness, Mindfulness for Life, Intervention, Emotion Regulation, Organizational Outcomes, Randomized Controlled Trial
- Medical subject headings
- Emotional Regulation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mindfulness-Based Cognitive Therapy - Life Course Adaptation (MBCT-L)Behavioural
MBCT-L (Mindfulness-Based Cognitive Therapy for Life) Is a structered, group-based intervention developed for use with healthy adults. The programs runs for 8 consecutive weeks, with sessions lasting 2 hours and 15 minutes. It includes formal and informal mindfulness practices, exercises to develop cognitive and emotion awareness, with elements adapted from cognitive therapy. The course was designed to support participants in cultivating habits that increase emotion regulation and psychological well-being. Home practice is assigned daily using audio-guided meditations. The intervention is standardized and delivered by a instructor trained under Oxford Mindfulness Centre (OMC) protocols. MBCT-L is distinct from the clinical MBCT model used for relapse prevention. And it is also disting from other Mindfulness-Based interventions as it uses different exercises than, for example, Mindfulness-Based Stress Reduction which emphasis stress theories in the intervention.
| Study group | Role | What they receive |
|---|---|---|
| Mindfulness-Based Cognitive Therapy - Life Course Adaptation (MBCT-L) | Experimental | Mindfulness For Life (MBCT-L) is an adapted version of Mindfulness-Based Cognitive Therapy, designed for the general population. While rooted in the original MBCT program, which was developed for preventing depressive relapse, Mindfulness for Life is tailored to increase the levels of psychological well-being, emotional resilience and mental health outcomes in non-clinical populations.
The program consist of 8 weekly sessions of 2 hours and 15 minutes, complemented by guide daily home practice. Participants are taught mindfulness meditation practices, cognitive-behavioral strategies, and experiential exercises aimed at enhancing self-awareness and emotional regulation. The intervention follows the standardized 'Mindfulness for Life' curriculum, as developed by the Oxford Mindfulness Foundation (OMF), and is delivered by an instructor trained in the approach through OMF. Receives: Behavioral: Mindfulness-Based Cognitive Therapy - Life Course Adaptation (MBCT-L) |
| Wait-List Control Group | No intervention | Participants in the wait-list control group will not receive the intervention during the initial study period but will be offered access to the Mindfulness for Life (MBCT-L) program after the initial phase of the study ends. For the first 8 weeks, they will not receive any structured psychological intervention as part of the study. They will continue any usual care or personal routines, an they will complete the same assements at equivalent time points. After this initial waiting period and completion of the first follow-up assessment, participants will then begin the Mindfulness for Life (MBCT-L) program. |
| Wait-List Control Group Phase 2 | No intervention | This is the second phase of a two-period crossover study. During this phase, participants assigned to the wait-list control condition do not receive any psychological intervention or active treatment. They continue with their usual activities and complete outcome assessments. In Phase 1 of the trial, the participants assigned to this group received the MBCT-L interventions. |
| Mindfulness for Life - Mindfulness- Based Cognitive Therapy Adaptation (MBCT-L) Phase 2 | Experimental | This is the second phase of a two-period crossover study. During this phase, participants who were originally assigned to the wait-list control group now receive the MBCT-L intervention. Receives: Behavioral: Mindfulness-Based Cognitive Therapy - Life Course Adaptation (MBCT-L) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Multidimensional State Mindfulness Questionnaire (MSMQ)
This scale is used to measure daily changes in state mindfulness. Participants will self-report levels of acting with awareness, nonjudgemental acceptance and present-moment attention in the context of their work day. The Multidimensional State Mindfulness Questionnaire (MSMQ) includes 9 items, rated on a Likert-type scale, and is designed to capture mindfulness as it fluctuates over time. Data will be collected across three daily diary periods: a baseline period before any intervention, a second period following the first 8-week phase, and a final period conducted after the second 8-week phase, once the crossover is complete. This structure allows for the examination of both between-group and within-subject changes in state mindfulness associated with the intervention.
Measured: Baseline (pre-intervention), week 8 (post-first phase), and week 16 (end of study following crossover).
Secondary outcomes (9)
Metacognitive Processes of Decentering - State Scale (MPoD-s)
The Metacognitive Processes of Decentering is a brief self-report measure designet to assess momentary decentering. The capacity to observe thoughts and emotions with perspective and distance from one's experience. The current implementations includes two items: "I can watch my thoughts and emotions come and go like clouds" and "I am more than my thoughts and feelings," rated on a Likert scale. The third decentering item was omitted to preserve conceptual compatibility with related constructs. The scale will be used in three periods of daily diary thought the study, first one after interventions, post-interventions phase 1, and at the end of the study after the crossover is complete.
Measured: Baseline (pre-intervention), week 8 (post-first phase), and week 16 (end of study following crossover)
Positive Reframing
We used the Positive Reframing subscale from the Brief COPE inventory to assess participants' tendency to reinterpret challenging situations in a more constructive or optimistic way. This subscale includes two items rated on Likert scale. This scale is part of the daily dairies.
Measured: Baseline (pre-intervention), week 8 (post-first phase), and week 16 (end of study following crossover)
Positive and Negative Affect Schedule - Short Form (PANAS-SF)
PANAS-SF is a 20 item self-report measure used to assess two distinct dimensions of affect: positive affect and negative affect. The instructions to this questionnaire were adapted to a daily level. Participants were instructed to think about the affects they experienced through their work day. They rate the extent to which they have experienced specific emotions in the workplace today. This scale is part of the daily diaries.
Measured: Baseline (pre-intervention), week 8 (post-first phase), and week 16 (end of study following crossover).
Psychological Capital
Psychological Capital Questionnaire (PCQ-12) is the short version of PCQ-24. It measures four core components of psychological capital: hope (4 items), self-efficacy (3 items), resilience (3 items), and optimism (2 items). Each item is rated on a 6-point Likert scale. This scale is included in the daily diaries.
Measured: Baseline (pre-intervention), week 8 (post-first phase), and week 16 (end of study following crossover)
In-Role Job Performance
In-role job performance was assessed using a 7-item scale developed by Williams and Anderson (1991), designed to measure how well employees fulfill the formal requirements of their job as outlined in their job description. Respondents rate items reflecting task completion, responsibility fulfillment, and expected work duties (e.g., "I perform tasks that are expected of me," "I meet the formal requirements of my job") using a Likert-type scale. This was adapted to a daily level and included in the diaries.
Measured: Baseline (pre-intervention), week 8 (post-first phase), and week 16 (end of study following crossover)
Short Index of Job Satisfaction (SIJS)
The Short Index of Job Satisfaction (SIJS) is a brief, 5-item self-report instrument designed to assess global job satisfaction. Respondents rate each item on a 5-point Likert scale ranging from 1 ("strongly disagree") to 5 ("strongly agree"), with higher scores indicating greater overall satisfaction with one's job. The SIJS captures a unidimensional construct of job satisfaction and it has been adapted to a daily level. This scale was included in the daily diaries.
Measured: Baseline (pre-intervention), week 8 (post-first phase), and week 16 (end of study following crossover)
Single Item Sleep Quality Scale
This scale is a brief self-report measure designed to assess overall sleep quality. It uses a Likert scale from 0 to 10, where 0 represents the worst posible sleep and 10 the best of quality. This scale has favorable measurement characteristics similar to Pittsburgh Sleep Quality Index (PSQI). It is used in the daily diaries of this study.
Measured: Baseline (pre-intervention), week 8 (post-first phase), and week 16 (end of study following crossover)
Substance Use
Substance Use subscale is used from the Brief COPE inventory o assess the extent to which participants use alcohol or other substances as a coping strategy in response to stress. This subscale consists of two items rated on a Likert scale. In addition, we included three single-item questions to capture actual substance consumption: "How many cigarettes did you smoke yesterday?", "How many doses of alcohol did you consume yesterday?" (e.g., one 330 ml beer, one 150 ml glass of wine, or one 40 ml shot of spirits), and "Did you use any other substances that could alter your state of consciousness?" These items were designed to provide a more detailed, behaviorally anchored assessment of substance use on a daily basis. This scale is included in the daily diaries.
Measured: Baseline (pre-intervention), week 8 (post-first phase), and week 16 (end of study following crossover)
Single-item Emotion Regulation Strategies
A set of five single-item measures is included to assess key emotion regulation strategies in a daily context. Each item targeted a specific strategy: active coping ("I took active steps to improve the situation"), attention distraction ("I distracted myself from the situation or my feelings"), rumination ("I thought repeatedly about the situation or my feelings"), cognitive reappraisal ("I tried to change my perspective on the situation or change how I think about it"), and emotional suppression ("I held back from expressing my emotions"). Respondents rated each item on a Likert-type scale reflecting the extent to which they used that strategy on a given day. This items were included in the daily diaries.
Measured: Baseline (pre-intervention), week 8 (post-first phase), and week 16 (end of study following crossover)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Jul 2025
- Study start30 Jul 2025
- Primary completion12 Dec 2025
- Study completion12 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Mindfulness Based Cognitive TherapyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Crossover
- Model description
- This study uses a two-period crossover design. Participants are randomly assigned to one of two sequences: (1) immediate intervention with Mindfulness-Based Cognitive Therapy for Life (MBCT-L) followed by a no-treatment follow-up period, or (2) initial wait-list control with no intervention followed by MBCT-L. Each phase lasts 8 weeks, with outcome assessments conducted at the end of each phase. The baseline measurement preintervention is in the week preceding the start of the first phase of the study.This design allows for both between-group comparisons during the first phase and within-subject comparisons across the two phases.
- Masking
- None (open label)
- Enrolment
- 340 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Bucharest
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Cezar Giosan, University of Bucharest
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07069361
- Sponsor's protocol ID
- 008
- Acronym
- MEROC
- Status last verified
- Sep 2026
- First submitted
- 7 Jul 2025
- Last updated
- 15 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: All IPD that underlie results in a publication
Publications
Hanley AW, de Vibe M, Solhaug I, Farb N, Goldin PR, Gross JJ, Garland EL. Modeling the mindfulness-to-meaning theory's mindful reappraisal hypothesis: Replication with longitudinal data from a randomized controlled study. Stress Health. 2021 Oct;37(4):778-789. doi: 10.1002/smi.3035. Epub 2021 Mar 9.
PubMed 33607697Wang Y, Garland EL, Farb NAS. An experimental test of the mindfulness-to-meaning theory: Casual pathways between decentering, reappraisal, and well-being. Emotion. 2023 Dec;23(8):2243-2258. doi: 10.1037/emo0001252. Epub 2023 May 11.
PubMed 37166828
Study at a glance
From the registry record, last updated by the sponsor on 15 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Role of Mindful Emotion Regulation in Organizational Contexts: A Workplace Experiment
- ClinicalTrials.gov ID
- NCT07069361
- Acronym / sponsor ID
- MEROC / 008
- Conditions
- Mindfulness Based Cognitive Therapy, Wait-List Control, Emotion Regulation, Organizational Context
- Keywords
- Mindfulness, Mindfulness for Life, Intervention, Emotion Regulation, Organizational Outcomes, Randomized Controlled Trial
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 340 participants (actual)
- Lead sponsor
- University of BucharestUniversity, hospital or other
- Study start
- 30 Jul 2025 (actual)
- Primary completion
- 12 Dec 2025 (actual)
- Study completion
- 12 Dec 2025 (actual)
- First posted
- 16 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized controlled trial investigates the effects of an 8-week mindfulness-based interventions, Mindfulness for Life (MBCT-L) on daily emotion regulation, psychological functioning, and work-related outcomes. The primary objective of this study is to investigate the underlying mechanism of change between mindfulness and job performance and satisfaction.
Detailed description
This study investigates the mechanisms by which mindfulness training influences positive affect, job performance, and satisfaction in organizational settings. Employing a two-period crossover design, participants receive an 8-week Mindfulness for Life (MBCT-L) intervention. Guided by Mindfulness-to-Meaning theory, the investigator propose that increases in mindfulness enhance positive affect through improved decentering and positive reframing. In line with the Broaden-and-Build theory, it is hypothesized that heightened positive affect leads to better in-role job performance and higher job satisfaction by increasing psychological capital. The primary objective is to elucidate these mediational pathways, thereby advancing our understanding of how mindfulness interventions can foster improve emotion regulation and organizational functioning.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 4
- Model description
- This study uses a two-period crossover design. Participants are randomly assigned to one of two sequences: (1) immediate intervention with Mindfulness-Based Cognitive Therapy for Life (MBCT-L) followed by a no-treatment follow-up period, or (2) initial wait-list control with no intervention followed by MBCT-L. Each phase lasts 8 weeks, with outcome assessments conducted at the end of each phase. The baseline measurement preintervention is in the week preceding the start of the first phase of the study.This design allows for both between-group comparisons during the first phase and within-subject comparisons across the two phases.
| Arm | Type | Receives |
|---|---|---|
| Mindfulness-Based Cognitive Therapy - Life Course Adaptation (MBCT-L) | Experimental | Behavioral: Mindfulness-Based Cognitive Therapy - Life Course Adaptation (MBCT-L)Mindfulness For Life (MBCT-L) is an adapted version of Mindfulness-Based Cognitive Therapy, designed for the general population. While rooted in the original MBCT program, which was developed for preventing depressive relapse, Mindfulness for Life is tailored to increase the levels of psychological well-being, emotional resilience and mental health outcomes in non-clinical populations. The program consist of 8 weekly sessions of 2 hours and 15 minutes, complemented by guide daily home practice. Participants are taught mindfulness meditation practices, cognitive-behavioral strategies, and experiential exercises aimed at enhancing self-awareness and emotional regulation. The intervention follows the standardized 'Mindfulness for Life' curriculum, as developed by the Oxford Mindfulness Foundation (OMF), and is delivered by an instructor trained in the approach through OMF. |
| Wait-List Control Group | No intervention | –Participants in the wait-list control group will not receive the intervention during the initial study period but will be offered access to the Mindfulness for Life (MBCT-L) program after the initial phase of the study ends. For the first 8 weeks, they will not receive any structured psychological intervention as part of the study. They will continue any usual care or personal routines, an they will complete the same assements at equivalent time points. After this initial waiting period and completion of the first follow-up assessment, participants will then begin the Mindfulness for Life (MBCT-L) program. |
| Wait-List Control Group Phase 2 | No intervention | –This is the second phase of a two-period crossover study. During this phase, participants assigned to the wait-list control condition do not receive any psychological intervention or active treatment. They continue with their usual activities and complete outcome assessments. In Phase 1 of the trial, the participants assigned to this group received the MBCT-L interventions. |
| Mindfulness for Life - Mindfulness- Based Cognitive Therapy Adaptation (MBCT-L) Phase 2 | Experimental | Behavioral: Mindfulness-Based Cognitive Therapy - Life Course Adaptation (MBCT-L)This is the second phase of a two-period crossover study. During this phase, participants who were originally assigned to the wait-list control group now receive the MBCT-L intervention. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Age between 18 and 65 years
- Full-time Workers
Key exclusion criteria (6 listed)
- Experiencing Hallucinations
- Experiencing psychotic symptoms
- Recieving psychotropic medications
- Experiencing legal or health issues that would prevent them to attend the sessions.
- Have had participated in a Mindfulness-Based course in the last 2 years.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Mindfulness-Based Cognitive Therapy - Life Course Adaptation (MBCT-L)MBCT-L (Mindfulness-Based Cognitive Therapy for Life) Is a structered, group-based intervention developed for use with healthy adults. The programs runs for 8 consecutive weeks, with sessions lasting 2 hours and 15 minutes. It includes formal and informal mindfulness practices, exercises to develop cognitive and emotion awareness, with elements adapted from cognitive therapy. The course was designed to support participants in cultivating habits that increase emotion regulation and psychological well-being. Home practice is assigned daily using audio-guided meditations. The intervention is standardized and delivered by a instructor trained under Oxford Mindfulness Centre (OMC) protocols. MBCT-L is distinct from the clinical MBCT model used for relapse prevention. And it is also disting from other Mindfulness-Based interventions as it uses different exercises than, for example, Mindfulness-Based Stress Reduction which emphasis stress theories in the intervention. | Behavioural | Mindfulness for Life - Mindfulness- Based Cognitive Therapy Adaptation (MBCT-L) Phase 2, Mindfulness-Based Cognitive Therapy - Life Course Adaptation (MBCT-L) |
Primary outcome
Multidimensional State Mindfulness Questionnaire (MSMQ)
Time frame: Baseline (pre-intervention), week 8 (post-first phase), and week 16 (end of study following crossover).
This scale is used to measure daily changes in state mindfulness. Participants will self-report levels of acting with awareness, nonjudgemental acceptance and present-moment attention in the context of their work day. The Multidimensional State Mindfulness Questionnaire (MSMQ) includes 9 items, rated on a Likert-type scale, and is designed to capture mindfulness as it fluctuates over time. Data will be collected across three daily diary periods: a baseline period before any intervention, a second period following the first 8-week phase, and a final period conducted after the second 8-week phase, once the crossover is complete. This structure allows for the examination of both between-group and within-subject changes in state mindfulness associated with the intervention.
9 secondary outcomes
Metacognitive Processes of Decentering - State Scale (MPoD-s)
Time frame: Baseline (pre-intervention), week 8 (post-first phase), and week 16 (end of study following crossover)
Positive Reframing
Time frame: Baseline (pre-intervention), week 8 (post-first phase), and week 16 (end of study following crossover)
Positive and Negative Affect Schedule - Short Form (PANAS-SF)
Time frame: Baseline (pre-intervention), week 8 (post-first phase), and week 16 (end of study following crossover).
Psychological Capital
Time frame: Baseline (pre-intervention), week 8 (post-first phase), and week 16 (end of study following crossover)
In-Role Job Performance
Time frame: Baseline (pre-intervention), week 8 (post-first phase), and week 16 (end of study following crossover)
Short Index of Job Satisfaction (SIJS)
Time frame: Baseline (pre-intervention), week 8 (post-first phase), and week 16 (end of study following crossover)
Single Item Sleep Quality Scale
Time frame: Baseline (pre-intervention), week 8 (post-first phase), and week 16 (end of study following crossover)
Substance Use
Time frame: Baseline (pre-intervention), week 8 (post-first phase), and week 16 (end of study following crossover)
Single-item Emotion Regulation Strategies
Time frame: Baseline (pre-intervention), week 8 (post-first phase), and week 16 (end of study following crossover)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Sep 2026.
- Background: PubMed 33607697Hanley AW, de Vibe M, Solhaug I, Farb N, Goldin PR, Gross JJ, Garland EL. Modeling the mindfulness-to-meaning theory's mindful reappraisal hypothesis: Replication with longitudinal data from a randomized controlled study. Stress Health. 2021 Oct;37(4):778-789. doi: 10.1002/smi.3035. Epub 2021 Mar 9.
- Background: PubMed 37166828Wang Y, Garland EL, Farb NAS. An experimental test of the mindfulness-to-meaning theory: Casual pathways between decentering, reappraisal, and well-being. Emotion. 2023 Dec;23(8):2243-2258. doi: 10.1037/emo0001252. Epub 2023 May 11.
- Individual participant dataSharing planned: Yes. All IPD that underlie results in a publication
Related trials for Mindfulness Based Cognitive Therapy
RecruitingPhase 2
Mindfulness-based Psilocybin Therapy for PTSD
Post Traumatic Stress Disorder, Depression - Major Depressive Disorder
Not yet recruiting
A Digital Mindfulness-Based Program for OCD
Obsessive-Compulsive Disorder (OCD)
Active, not recruiting
Comparing Cognitive-Behavioral Therapy Versus Mindfulness-Based Therapy for Autistic Adults
Autism Spectrum Disorder, Depression
Active, not recruiting
Exercise and Mindfulness Intervention for Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer
Cancer Patients, Chemotherapy-Induced Peripheral Neuropathy
Not yet recruiting
Effectiveness of a Mindfulness-Based Cognitive Behavioral Mobile Intervention for Misophonia
Misophonia, Misophonia Treatment
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Mindfulness-Based Cognitive Therapy - Life Course Adaptation (MBCT-L) in people with Mindfulness Based Cognitive Therapy and Wait-List Control, run by University of Bucharest at 1 site in Romania.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Romania. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Multidimensional State Mindfulness Questionnaire (MSMQ) (time frame: Baseline (pre-intervention), week 8 (post-first phase), and week 16 (end of study following crossover).). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07069361, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2026.